Latest Period
Q2 2026
Security Snapshot
CONMED Corp - Common Stock (CNMD) Institutional Ownership
CUSIP: 207410101
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
242
Shares (Excl. Options)
34,064,003
Price
$32.73
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- CNMD on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 34,064,003
- Total 13F value
- $1,115,624,705
- Portfolio coverage rank
- 0%
- Share change
- +64,188
- Value change
- -$344,107
- Number of holders
- 242
- Shares outstanding
- 30,839,429
- SEC-reported price per share
- $43.20
- Insider filing price
- $43.20
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CNMD - CONMED Corp - Common Stock is tracked under CUSIP 207410101.
- 242 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 234 to 242 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,205,836,891 to $1,115,624,705.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 242 institutions filings for Q2 2026.
Security key
207410101
Latest holder period
Q2 2026
13F holders
242
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
CNMD full holder history
CONMED Corp SEC filings
CONMED Corp company facts
CONMED Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 207410101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
CNMD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | $243,705,287 | 4,679,441 | BlackRock, Inc. | 30 Jun 2025 | |||
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.9% | $74,994,529 | 2,120,886 | Vanguard Portfolio Management | 31 Mar 2026 | |||
| FULLER & THALER ASSET MANAGEMENT, INC. | 5.6% | $94,115,868 | 1,740,630 | Fuller & Thaler Asset Management, Inc. | 30 Jun 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.2% | $57,250,315 | 1,619,070 | Vanguard Capital Management | 31 Mar 2026 | |||
| Capital Research Global Investors | 3.3% | $48,569,433 | 1,032,733 | Capital Research Global Investors | 30 Sep 2025 |
As of 30 Jun 2026, 242 institutional investors reported holding 34,064,003 shares of CONMED Corp - Common Stock (CNMD). This represents 110% of the company’s total 30,839,429 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
85%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 16% | 4,820,739 | -0.09% | 0% | $157,782,788 |
| EARNEST PARTNERS LLC | 8.1% | 2,505,295 | -2.5% | 0.3% | $81,998,305 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.1% | 2,188,761 | +5.4% | 0% | $71,638,148 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 5.1% | 1,579,917 | -3.8% | 0.14% | $51,710,696 |
| STATE STREET CORP | 4.6% | 1,417,468 | +2.4% | 0% | $46,393,728 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 1,355,728 | -2% | 0% | $44,372,977 |
| BANK OF AMERICA CORP /DE/ | 4.3% | 1,341,409 | -4.4% | 0% | $43,904,317 |
| DIMENSIONAL FUND ADVISORS LP | 4.3% | 1,317,370 | -5.4% | 0.01% | $43,121,568 |
| SEI INVESTMENTS CO | 3.2% | 988,151 | -1.6% | 0.03% | $32,342,166 |
| Invenomic Capital Management LP | 2.7% | 842,162 | -9.9% | 1.6% | $27,563,962 |
| Capital Research Global Investors | 2.7% | 823,636 | -11% | 0% | $26,957,606 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 790,138 | +6.4% | 0% | $25,866,562 |
| TWO SIGMA INVESTMENTS, LP | 2.4% | 728,976 | -6.8% | 0.02% | $23,859,384 |
| Allspring Global Investments Holdings, LLC | 2% | 618,447 | +6.1% | 0.03% | $20,260,323 |
| COOKE & BIELER LP | 1.9% | 573,498 | -42% | 0.22% | $18,770,590 |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1.7% | 538,245 | 0.48% | $17,616,759 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.5% | 476,885 | +14% | 0.01% | $15,608,446 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.5% | 471,022 | -1.6% | 0% | $15,416,550 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.4% | 441,361 | -32% | 0.09% | $14,445,802 |
| GOLDMAN SACHS GROUP INC | 1.4% | 436,830 | -8.4% | 0% | $14,297,447 |
| AMERIPRISE FINANCIAL INC | 1.4% | 436,289 | -5.2% | 0% | $14,279,731 |
| LSV ASSET MANAGEMENT | 1.3% | 402,400 | +2995% | 0.02% | $13,171,000 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 1.2% | 370,690 | +17% | 0.04% | $12,132,684 |
| NORTHERN TRUST CORP | 1.1% | 351,359 | +5.1% | 0% | $11,499,980 |
| GLENMEDE TRUST CO NA | 1% | 323,701 | +17% | 0.05% | $10,594,733 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 34,064,003 | $1,115,624,705 | -$344,107 | $32.73 | 242 |
| 2026 Q1 | 34,098,458 | $1,205,836,891 | -$1,735,300 | $35.36 | 234 |
| 2025 Q4 | 33,989,564 | $1,379,979,079 | -$44,055,362 | $40.60 | 265 |
| 2025 Q3 | 34,557,772 | $1,625,415,179 | -$32,316,019 | $47.03 | 269 |
| 2025 Q2 | 34,975,375 | $1,823,206,095 | -$41,386,072 | $52.08 | 274 |
| 2025 Q1 | 35,601,941 | $2,150,144,905 | -$20,487,188 | $60.39 | 278 |
| 2024 Q4 | 35,792,657 | $2,450,093,611 | +$125,573,506 | $68.44 | 278 |
| 2024 Q3 | 33,926,666 | $2,440,398,260 | -$123,941,909 | $71.92 | 288 |
| 2024 Q2 | 35,708,869 | $2,475,216,987 | -$1,086,084 | $69.32 | 290 |
| 2024 Q1 | 35,579,346 | $2,849,068,239 | -$67,947,309 | $80.08 | 291 |
| 2023 Q4 | 36,107,785 | $3,954,476,972 | +$63,168,795 | $109.51 | 304 |
| 2023 Q3 | 35,550,402 | $3,585,822,683 | +$9,282,981 | $100.85 | 272 |
| 2023 Q2 | 35,195,844 | $4,782,462,359 | -$128,174,660 | $135.89 | 260 |
| 2023 Q1 | 36,310,840 | $3,771,467,991 | +$69,510,560 | $103.86 | 230 |
| 2022 Q4 | 36,122,982 | $3,202,451,228 | +$90,513,776 | $88.64 | 237 |
| 2022 Q3 | 35,168,400 | $2,819,895,579 | +$50,445,452 | $80.17 | 238 |
| 2022 Q2 | 33,875,370 | $3,246,122,242 | +$139,316,195 | $95.76 | 271 |
| 2022 Q1 | 32,262,003 | $4,791,955,701 | +$14,731,433 | $148.55 | 269 |
| 2021 Q4 | 32,151,856 | $4,556,918,750 | +$83,115,813 | $141.76 | 259 |
| 2021 Q3 | 31,531,141 | $4,126,330,762 | +$14,770,680 | $130.83 | 257 |
| 2021 Q2 | 31,396,924 | $4,315,140,658 | +$62,149,874 | $137.43 | 248 |
| 2021 Q1 | 31,038,884 | $4,053,594,117 | +$77,303,462 | $130.59 | 236 |
| 2020 Q4 | 30,817,893 | $3,452,630,680 | +$80,458,500 | $112.00 | 241 |
| 2020 Q3 | 30,289,537 | $2,382,840,313 | +$64,447,834 | $78.67 | 232 |
| 2020 Q2 | 29,535,076 | $2,125,219,531 | +$45,226,693 | $71.99 | 220 |